President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks ...

Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today shared positive updated results from inMMyCAR, the ongoing first-in-human Phase 1 study of ...

After his life as a Navy SEAL ended, Jonathan “Johnny” Wilson found it difficult to function in society. After deployments to ...

Fortune favours the fabulous, which is perhaps why the sun is out once again for another year of Mighty Hoopla: the UK’s ...

The board for Oregon counselors has withdrawn discipline of a counselor after being sued for allegedly violating his First Amendment rights.

Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC trial show 71% (5/7) patients resected following VTP with a consistent and well-tolerated safety profile – – Early clinical ...

Cosmic beings, the first week of June begins with us still very much feeling the aftermath of the Sagittarius full moon that ...

In this article, we discuss the Jeff Bezos Stock Portfolio: Top 10 Stock Picks. Jeff Bezos is a visionary entrepreneur, investor, and engineer who fundamentally reshaped global commerce and digital ...

At Google I/O 2026, Google opened researcher registration for Hypothesis Generation — the first public-facing tool built on Co-Scientist, its multi-agent AI system for scientific hypothesis generation ...

“I remember when my mother and her friends went on a pilgrimage,” recalls Surya Maguluri, co-founder and CTO of Litemed. “While everyone else walked around easily, my mother could only join them later ...

In combination with Keytruda, the antibody-drug conjugate slowed progression compared to anti-PD-1 therapy alone.